Transthyretin Amyloid Cardiomyopathy Risk Evaluation in a Cohort of Patients With Heart Failure

por Suh, Angie A, Shaw, Paul B, Jeong, Mark Y, Olson, Kari L, Delate, Thomas
Publicado 2023

High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling

por Zhao, Yuanbiao, Londono, Pilar, Cao, Yingqiong, Sharpe, Emily J., Proenza, Catherine, O'Rourke, Rebecca, Jones, Kenneth L., Jeong, Mark Y., Walker, Lori A., Buttrick, Peter M., McKinsey, Timothy A., Song, Kunhua
Publicado 2015

Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

por Pioner, Josè Manuel, Racca, Alice W., Klaiman, Jordan M., Yang, Kai-Chun, Guan, Xuan, Pabon, Lil, Muskheli, Veronica, Zaunbrecher, Rebecca, Macadangdang, Jesse, Jeong, Mark Y., Mack, David L., Childers, Martin K., Kim, Deok-Ho, Tesi, Chiara, Poggesi, Corrado, Murry, Charles E., Regnier, Michael
Publicado 2016

HDAC6 modulates myofibril stiffness and diastolic function of the heart

por Lin, Ying-Hsi, Major, Jennifer L., Liebner, Tim, Hourani, Zaynab, Travers, Joshua G., Wennersten, Sara A., Haefner, Korey R., Cavasin, Maria A., Wilson, Cortney E., Jeong, Mark Y., Han, Yu, Gotthardt, Michael, Ferguson, Scott K., Ambardekar, Amrut V., Lam, Maggie P.Y., Choudhary, Chunaram, Granzier, Henk L., Woulfe, Kathleen C., McKinsey, Timothy A.
Publicado 2022

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy

por Knight, Walter E., Cao, Yingqiong, Lin, Ying-Hsi, Chi, Congwu, Bai, Betty, Sparagna, Genevieve C., Zhao, Yuanbiao, Du, Yanmei, Londono, Pilar, Reisz, Julie A., Brown, Benjamin C., Taylor, Matthew R.G., Ambardekar, Amrut V., Cleveland, Joseph C., McKinsey, Timothy A., Jeong, Mark Y., Walker, Lori A., Woulfe, Kathleen C., D'Alessandro, Angelo, Chatfield, Kathryn C., Xu, Hongyan, Bristow, Michael R., Buttrick, Peter M., Song, Kunhua
Publicado 2021